Huimeng Liu, Jian Lei, Yuewei Liu, Tong Zhu, Kahung Chan, Xi Chen, Jing Wei, Furong Deng, Ge Li, Yunxing Jiang, Lijun Bai, Kai Wang, Juan Chen, Yang Lan, Xi Xia, Jinxi Wang, Chen Wei, Yinxiang Li, Renjie Chen, Jicheng Gong, Xiaoli Duan, Kai Zhang, Haidong Kan, Xiaoming Shi, Xinbiao Guo, Shaowei Wu
{"title":"Hospital admissions attributable to reduced air pollution due to clean-air policies in China","authors":"Huimeng Liu, Jian Lei, Yuewei Liu, Tong Zhu, Kahung Chan, Xi Chen, Jing Wei, Furong Deng, Ge Li, Yunxing Jiang, Lijun Bai, Kai Wang, Juan Chen, Yang Lan, Xi Xia, Jinxi Wang, Chen Wei, Yinxiang Li, Renjie Chen, Jicheng Gong, Xiaoli Duan, Kai Zhang, Haidong Kan, Xiaoming Shi, Xinbiao Guo, Shaowei Wu","doi":"10.1038/s41591-025-03515-y","DOIUrl":null,"url":null,"abstract":"<p>The Air Pollution Prevention and Control Action Plan (APPCAP) is considered to be the most stringent air pollution control policy in China implemented since 2013. This policy is a milestone in China to mitigate serious air pollution. However, health benefits attributable to reduced fine-particulate air pollution after the implementation of the APPCAP have not been quantitatively estimated on a PM<sub>2.5</sub> constituent-specific and morbidity cause-specific basis. Here we conducted a nationwide case-crossover study based on hospital admission records in 292 Chinese cities during 2013-2017. Compared with 2013, the annual average concentrations of PM<sub>2.5</sub> and black carbon (BC) in 2017 decreased by 28.61% and 20.35%, respectively. As a result, the average relative reductions in annual attributable fractions of nine major cause-specific hospital admissions associated with PM<sub>2.5</sub> and BC were 30.00% and 21.14%, respectively, among which annual attributable fraction for depression showed the largest reduction. Nationally, cities with higher reductions in PM<sub>2.5</sub> and BC were found to have higher absolute reductions in annual hospital admission attributable fractions associated with PM<sub>2.5</sub> and BC, and geographic inequality in health benefits still existed. Our study highlights the substantial wide-ranging health benefits of reduced PM<sub>2.5</sub> and BC levels following the nationwide implementation of the APPCAP in China.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"10 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03515-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The Air Pollution Prevention and Control Action Plan (APPCAP) is considered to be the most stringent air pollution control policy in China implemented since 2013. This policy is a milestone in China to mitigate serious air pollution. However, health benefits attributable to reduced fine-particulate air pollution after the implementation of the APPCAP have not been quantitatively estimated on a PM2.5 constituent-specific and morbidity cause-specific basis. Here we conducted a nationwide case-crossover study based on hospital admission records in 292 Chinese cities during 2013-2017. Compared with 2013, the annual average concentrations of PM2.5 and black carbon (BC) in 2017 decreased by 28.61% and 20.35%, respectively. As a result, the average relative reductions in annual attributable fractions of nine major cause-specific hospital admissions associated with PM2.5 and BC were 30.00% and 21.14%, respectively, among which annual attributable fraction for depression showed the largest reduction. Nationally, cities with higher reductions in PM2.5 and BC were found to have higher absolute reductions in annual hospital admission attributable fractions associated with PM2.5 and BC, and geographic inequality in health benefits still existed. Our study highlights the substantial wide-ranging health benefits of reduced PM2.5 and BC levels following the nationwide implementation of the APPCAP in China.
期刊介绍:
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors.
Nature Medicine consider all types of clinical research, including:
-Case-reports and small case series
-Clinical trials, whether phase 1, 2, 3 or 4
-Observational studies
-Meta-analyses
-Biomarker studies
-Public and global health studies
Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.